Cargando…
Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease
A novel class of benzamide-hydroxypyridinone (HPO) derivatives were innovatively designed, synthesised, and biologically evaluated as potential multitargeting candidates for the treatment of Alzheimer's disease (AD) through pharmacophores-merged approaches based on lead compounds 18d, benzyloxy...
Autores principales: | Jiang, Xiaoying, Guo, Jianan, Zhang, Changjun, Gu, Jinping, Zhou, Tao, Bai, Renren, Xie, Yuanyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8510601/ https://www.ncbi.nlm.nih.gov/pubmed/34607518 http://dx.doi.org/10.1080/14756366.2021.1978081 |
Ejemplares similares
-
Functionality study of chalcone-hydroxypyridinone hybrids as tyrosinase inhibitors and influence on anti-tyrosinase activity
por: Singh, L. Ravithej, et al.
Publicado: (2020) -
Hydroxypyridinone-Diamine Hybrids as Potential Neuroprotective Agents in the PC12 Cell-Line Model of Alzheimer’s Disease
por: Lohou, Elodie, et al.
Publicado: (2019) -
Dual-target anti-Alzheimer’s disease agents with both iron ion chelating and monoamine oxidase-B inhibitory activity
por: Mi, Zhisheng, et al.
Publicado: (2019) -
A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo
por: Wang, Xiaomei, et al.
Publicado: (2019) -
Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model
por: Dambuza, Ntokozo S., et al.
Publicado: (2015)